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DOI 10.1016/j.ccr.2011.02.007SUMMARYp120-catenin (p120ctn) interacts with E-cadherin, but to our knowledge, no formal proof that p120ctn func-
tions as a bona fide tumor suppressor gene has emerged to date. We report herein that p120ctn loss leads to
tumor development in mice. We have generated a conditional knockout model of p120ctn whereby mice
develop preneoplastic and neoplastic lesions in the oral cavity, esophagus, and squamous forestomach.
Tumor-derived cells secrete granulocyte macrophage colony-stimulating factor (GM-CSF), macrophage
colony-stimulating factor (M-CSF), monocyte chemotactic protein-1 (MCP-1), and tumor necrosis factor-
a (TNFa). The tumors contain significant desmoplasia and immune cell infiltration. Immature myeloid cells
comprise a significant percentage of the immune cells present and likely participate in fostering a favorable
tumor microenvironment, including the activation of fibroblasts.INTRODUCTION
Cell-cell junctions are critical for cell adhesion during normal
epithelial homeostasis. The cardinal feature of the adherens
junctions is the interaction between the cytoplasmic tail of clas-
sical type I (E-cadherin) and type II cadherins, and p120-catenin
(p120ctn, also referred to as catenin, delta1, or Ctnnd1), which
engenders stability of this specific junctions complex at the cell
membrane (Davis et al., 2003; Ireton et al., 2002; Xiao et al.,
2003). Recently, it was revealed by X-ray crystallography thatSignificance
Oral squamous cell cancers (OSCCs) and esophageal squamo
worldwide. The molecular pathogenesis underlying these ca
epithelial homeostasis through the adherens junctions. p120c
as a basis for the generation of a conditional knockout mouse
phenotype accompanied by induction of prosurvival signals, de
p120ctn loss in this mouse model proves its tumor suppresso
early detection, molecular imaging, and targeted therapeutics
470 Cancer Cell 19, 470–483, April 12, 2011 ª2011 Elsevier Inc.p120 isoform 4A is in complex with the juxtamembrane domain
core region (JMD(core)) of E-cadherin (Ishiyama et al., 2010).
Loss of p120ctn or its phosphorylation on serine-threonine resi-
dues is able to destabilize E-cadherin (Fukumoto et al., 2008).
Thus, p120ctn regulates cadherin stability and turnover.
The balance between adhesion and migration is regulated
further by p120ctn’s ability to regulate the activities of RhoA,
Rac, and Cdc42 through the amino terminus of p120ctn, thereby
orchestrating exquisite actin dynamics (Reynolds and Roczniak-
Ferguson, 2004). Furthermore, the bridge between p120ctn andus cell cancers (ESCCs) represent common human cancers
ncers involves p120-catenin (p120ctn), which is critical to
tn loss or mislocalization in these specific cancers served
model, revealing a dramatic invasive squamous cell cancer
smoplasia, and recruitment of immaturemyeloid cells. Thus,
r role and establishes a platform for strategies designed for
in these cancers that have been elusive to date.
Figure 1. p120ctn and E-Cadherin Expression in ESCC
(A) p120ctn expression by IHC reveals cell membrane locali-
zation in normal tissue, whereas cytoplasmic mislocalization
and decreased or absent expression are detected in ESCC.
Scale bars, 50 mM.
(B) Quantification of p120ctn and E-cadherin expression in
ESCC relative to matched adjacent normal esophagus (n = 69
paired samples). Fisher’s exact analysis demonstrates that
p120ctn and E-cadherin expression is coordinately regulated
(p = 0.017).
(C) Western blot analysis of human esophageal cancer cell
lines for p120ctn, E-cadherin, and N-cadherin expression,
with b-actin as loading control.
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et al., 2006).
p120ctn’s structure is highlighted by an amino-terminal
domain that has regulatory functions, a central Armadillo Repeat
domain (Arm), a nuclear export signal (NES), and a carboxyl-
terminal domain whose function(s) remains to be elucidated
(Anastasiadis et al., 2000). Isoforms of p120ctn result from differ-
ential splicing. Initiation at the first ATG start site (Isoform 1)
results in preferential expression in the mesenchymal compart-
ment, whereas isoforms that lack a coiled-coiled domain that
utilize the third start site (Isoform 3) are expressed in the epithelial
compartment. Not all isoforms express the NES.
It has become increasingly clear that loss, downregulation, or
mislocalization of p120ctn helps to define diverse tumor types in
the prostate, breast, pancreas, colon, skin, bladder, and endo-
metrium (Reynolds and Roczniak-Ferguson, 2004; Thoreson
and Reynolds, 2002; van Hengel and van Roy, 2007). Interest-
ingly, decreased expression is not typically observed in the entire
tumor but rather in regions of the tumor, similar to that observed
for E-cadherin loss (Birchmeier, 1995). This loss or mislocaliza-
tion of p120ctn frequently leads to E-cadherin destabilization,
endowing a cancer cell an advantage in cell migration by virtue
of abrogation of cell adhesion. Additionally, knockdown experi-
ments using shRNA to p120ctn have demonstrated that
p120ctn loss induces invasion in tumor cell lines with concomi-
tant loss or downregulation of E-cadherin (Macpherson et al.,
2007), although collective invasion might involve also concurrent
retention of membranous p120ctn and cadherin-mediated (P- or
E-cadherin) cell-cell contacts at least in vitro. In aggregate, these
data suggest a potential tumor suppressor role for p120ctn in
various cancer types, but to our knowledge, a causal role
in vivo has yet to be demonstrated unequivocally.
p120ctn loss in the mouse has been modeled in an attempt to
phenocopy human disease, but to date, no published mouseCancer Celmodel has yielded a cancer phenotype. Deletion
of p120ctn by homologous recombination in mice
results in embryonic lethality. Tissue-specific tar-
geting of p120ctn has been utilized to study the
role of p120ctn in development and tumorigenesis
(Davis and Reynolds, 2006). For example, p120ctn
loss results in impaired enamel development (Bar-
tlett et al., 2010). Targeted p120ctn deletion in the
embryonic salivary gland forces a loss of acinar
development and an adoption of a ductal cellfate. Although these mice die immediately in the postnatal
period, the salivary glands are distinguished by intraepithelial
dysplasia, but not cancer (Davis and Reynolds, 2006). p120ctn
loss in the skin results in epidermal hyperplasia and chronic
inflammation with loss of hair and body fat (Perez-Moreno
et al., 2006). Furthermore, the epidermis has evidence of NFkB
activation and mitotic defects such as aneuploidy, but no overt
cancer (Perez-Moreno et al., 2008). Recently, conditional
p120ctn loss in the small intestine and colon was found to result
in death by 21 days, with evidence of mucosal erosion and
bleeding, and recruitment of COX-2 expressing neutrophils, sug-
gesting an underlying barrier defect (Smalley-Freed et al., 2010).
Thus, to date, and to our knowledge, no tissue-specific p120ctn
knockout mouse models have been able to demonstrate that
p120ctn loss results in the development of invasive cancer.
The overarching goal of this study was to generate and char-
acterize mechanistically a genetic mouse model in which condi-
tional p120ctn loss in the squamous oral cavity, esophagus, and
forestomach results in cancer that phenocopies precisely the
histologic features of human oral and esophageal squamous
cell carcinomas (OSCCs, ESCCs, respectively). In so doing,
such a model might provide a platform for the consideration of
combinatorial therapeutics in ESCCs, OSCCs, and potentially
other squamous cell cancers.
RESULTS
p120ctn Expression Is Lost or Reduced in Esophageal
Cancer Tissues and Cell Lines
A human tissue microarray (TMA) with matched normal esopha-
geal and esophageal squamous cell cancer (ESCC) tissues was
evaluated for p120ctn expression by immunohistochemistry
(IHC) (Figure 1A). p120ctn has the expected membrane-associ-
ated localization in the normal esophageal squamous epithelium.l 19, 470–483, April 12, 2011 ª2011 Elsevier Inc. 471
Figure 2. Gross Pathology of L2Cre;p120ctnloxP/loxP Mice
(A) Two-month-old mice were analyzed by IF for p120ctn expression. Arrow
indicates normal cell membrane localization in L2Cre;p120ctn+/+ esophagi
(n = 4). p120ctn loss is evident in the esophagi of L2Cre;p120ctnloxP/loxP mice
(n = 4). Nonspecific staining of keratins can be observed in the cornified layers.
Scale bars, 50 mM.
(B) Gross lesions were detected in the spleen, tongue, esophagus, and
squamous forestomach of 9- to 12-month-old L2Cre;p120ctnloxP/loxP mice.
A reference ruler (centimeters) is included in each image for size comparison.
Arrows indicate the location of tumors.
(C) Gross pathology of a squamous forestomach tumor (indicated by an arrow)
and two enlarged lymph nodes (normally approximately 1–2 mm in diameter)
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cytoplasmic mislocalization (Figure 1B). There is a statistically
significant association (p = 0.017) between decreased p120ctn
and E-cadherin expression with odds ratio = 3.23 (95% CI:
1.13 < O.R. < 9.24). These data reveal that p120ctn and E-cad-
herin are coordinately decreased or lost in themajority of ESCCs,
and substantiate previous findings (Chung et al., 2007).
A panel of 14 human esophageal squamous tumor cell lines
wasanalyzed for p120ctn andE-cadherin expression (Figure 1C).
p120ctn expression was detected in all cell lines with different
isoforms observed in a subset of them. E-cadherin expression
was moderate to high in 11 of 14 cell lines, low in one (TE8),
and absent in two cell lines (HCE4, HCE7). p120ctn and E-cad-
herin expression correlated well in the cell lines. Interestingly,
the mesenchymal p120ctn isoform appears to be expressed in
HCE-4 and HCE-7 cells along with N-cadherin, consistent with
N-cadherin’s pattern of known mesenchymal expression.Conditional Deletion of p120ctn in the Oral Cavity,
Esophagus, and Forestomach Results in Invasive
Squamous Cell Cancer, Desmoplasia, and Inflammation
To elucidate the mechanistic roles of p120ctn in vivo, we
generated spatially targeted p120ctn deletion in the squamous
oral cavity, esophagus, and forestomach. We bred L2Cre and
p120loxP/loxP mice together to generate L2Cre;p120loxP/loxP
mice, where the L2 promoter is active specifically in the squa-
mous oral cavity, esophagus, and forestomach (Nakagawa
et al., 1997; Opitz et al., 2002). LacZ (Gt(Rosa) 26Tm1Sor) reporter
mice were crossed with L2Cre mice to determine the efficiency
of Cre recombination in the oral cavity, esophagus, and forest-
omach of mice. LacZ staining demonstrates effective recombi-
nation and, therefore, Cre expression in these specific tissues
(see Figure S1 available online). To verify p120ctn loss in
L2-Cre;p120loxP/loxP mice, p120ctn protein expression was as-
sessed by immunofluorescence (IF). p120ctn was effectively
lost in the epithelium in 2-month-old L2-Cre;p120loxP/loxP mice
compared to L2-Cre;p120+/+ control mice (Figure 2A).
Gross pathology examination of the oral cavities, esophagi,
and forestomachs of L2Cre;p120loxP/loxP mice revealed signifi-
cant masses in each of these tissues, along with splenomegaly
and local lymphadenopathy (Figures 2B and 2C). Histologic
analysis at 4–6 months of age revealed epithelial dysplasia
(data not shown). Histologic analysis at 9–12 months of age
demonstrated severe dysplasia with invasive squamous cancer
into the submucosa and muscle in L2Cre;p120loxP/loxP mice,
whereas all control mice (p120flox/flox, L2-Cre;p120+/+, and
L2-Cre;p120+/loxP) had no abnormalities (Figure 3A). Approxi-
mately 70% of L2Cre;p120loxP/loxP mice develop tumors
between 9 and 12 months of age, whereas no tumors were
detected in age-matched littermate control mice (Table S1;
p < 0.0001). Invasive esophageal cancer was detected as early
as 4 months of age in one L2Cre;p120loxP/loxP mouse. Some
esophageal tumors were poorly differentiated but displayed no
evidence of any obvious distant metastasis, although we cannotfrom a L2Cre;p120ctnloxP/loxP mouse. See also Table S1 and Figure S1. A total
of 23 L2Cre;p120ctnloxP/loxP mice and 23 control (five p120ctnloxP/loxP, ten
L2Cre;p120ctn+/+, and eight L2Cre;p120ctn+/loxP) mice were evaluated.
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ure 3A). The submucosa was altered with marked desmoplasia
and the striking presence of immune cell infiltration (Figure 3A).
Analysis of L2-Cre;p120loxP/loxP forestomachs revealed severe
hyperplasia, severe dysplasia, and invasive cancers into
the underlying desmoplastic and inflammatory stroma. (Fig-
ure 3A). The forestomachs of all control mice (p120flox/flox,
L2-Cre;p120+/+, and L2-Cre;p120+/loxP) revealed nomorphologic
changes (Figure 3A). Nearly identical results are evident in the
oral cavities of L2-Cre;p120loxP/loxP mice, namely invasive squa-
mous cell cancer with desmoplasia and immune cell infiltration
(Figure 3A).
We next evaluated E-cadherin expression in L2-Cre;
p120loxP/loxP mice. Significant loss of E-cadherin expression is
noted in L2-Cre;p120loxP/loxP mice compared to L2-Cre;p120+/+
control mice, with residual E-cadherin expression in some
L2-Cre;p120loxP/loxP mice where it is cytoplasmic (Figure 3B). In
some mice, whereas p120ctn is lost and E-cadherin is either
lost or cytoplasmic, there are occasional focal areas within
tumors that retain both p120ctn and E-cadherin at the cell
membrane (Figure 3C), the latter consistent with the notion of
collective invasion observed in A431 cells in vitro (Macpherson
et al., 2007).
Alterations in Proliferation and Differentiation
in L2-Cre/p120flox/flox Mice
Ki-67 and keratin 14 (K14), markers of proliferation, were evalu-
ated in esophageal tumors from L2-Cre;p120loxP/loxP mice.
Normal proliferating basal cells express Ki-67 and K14, whereas
normal differentiated suprabasal cells express keratins 4 and 13
(K4, K13, respectively) and harbor little proliferation. Ki-67
expression was significantly increased in the esophageal
epithelia and in the invasive cancers in L2-Cre;p120loxP/loxP
mice compared to control mice (Figure S2; p = 3 3 106). K14
expression was increased in the esophageal epithelia at
5 months of age, which ultimately expanded to the luminal
surface by 12 months of age (data not shown). K4 expression,
as evaluated by qPCR, is decreased 2.5-fold (p = 0.014) in
L2-Cre;p120loxP/loxP mice compared to L2-Cre;p120+/+ control
mice (data not shown). Invading tumor cells are K14 positive (Fig-
ure 3C). Interestingly, b-catenin expression was membranous in
the esophagi of L2-Cre;p120loxP/loxP mice (Figure 3C) but lost in
the oral cavity of the L2-Cre;p120loxP/loxP mice. Furthermore,
no alterations were apparent for epidermal growth factor
receptor (EGFR), c-myc, or K-ras by IHC in the tumors (data
not shown). However, p-Akt (but not p-Erk1/2 [p-Mapk]) was
increased in the tumors, as was p-Stat3, which might contribute
to tumorigenesis (Figure S2).
NFkB and Inflammatory Cells in the Tumor
Microenvironment
Given the significant recruitment of immune cells in the tumor
stroma, we hypothesized that NFkB activation may be present
in these lesions, as has been reported previously (Perez-Moreno
et al., 2006; Perez-Moreno et al., 2008). Indeed, this was
confirmed with robust NFkB induction in dysplasia and tumors,
thereby suggesting that this is an early event (Figure 4A). The
NFkB induction was evident also in the immune cells found in
the tumor stroma (Figure 4A).We then established cells from an esophageal tumor (desig-
nated as 714ET) as well as esophageal cell lines from
p120ctnloxP/loxP mice that in turn were infected with retroviral
Cre recombinase or a control vector (designated as F2-Cre
and F2-Tomato, respectively). Western blot analysis revealed
complete p120ctn loss in both F2-Cre and 714ET cells and re-
tained p120ctn expression in the control F2-Tomato cells (Fig-
ure 4B and quantified in Figure 4C, left panel). In F2-Cre and
714ET cells, there is activated p-NFkB (8-fold), p-Akt (4-fold),
and p-Stat3 (2-fold) (Figures 4B and 4C). Additionally, 714ET
cells were found to secrete significant amounts of granulocyte
macrophage colony-stimulating factor (GM-CSF), macrophage
colony-stimulating factor (M-CSF), monocyte chemotactic
protein-1 (MCP-1), and tumor necrosis factor-a (TNFa) (Fig-
ure 4D), but not other cytokines tested (IL-1b, IL-2, IL-4, IL-5,
IL-6, or IFNg; data not shown). GM-CSF has been suggested
to contribute to immature myeloid cell recruitment (Marigo
et al., 2010).
In order to characterize the immune cells in the tumormicroen-
vironment, we undertook a number of experiments. Splenic
weights in L2-Cre;p120loxP/loxP mice were 5-fold greater than in
control mice (p = 0.0004), and there was also leukocytosis with
increased segmented neutrophils, band neutrophils, eosino-
phils, and monocytes (Table S2). These findings suggested
that there may be an elevated production of circulating myeloid
lineage cells and that the invasive squamous cell cancers in the
L2-Cre;p120loxP/loxP mice might contribute to the recruitment of
these immune cells. Therefore, we analyzed the leukocyte frac-
tion (CD45+ cells) for immature myeloid cells (defined phenotyp-
ically as Gr-1+ CD11b+ cells), macrophages (F4/80+), T cells
(CD3+), B cells (CD19+), dendritic cells (CD11c+), and natural
killer (NK) cells (CD49b+). The percentage of CD45+ cells was
approximately the same for normal versus dysplastic versus
tumor tissues and spleens (Figure 4E). However, there was
a statistically significant increase (Figure S3) in immaturemyeloid
cell infiltration in dysplastic and tumor tissues (Figure 4E). In
dysplastic esophagi or forestomachs, the percentage of imma-
ture myeloid cells increased 4- to 8-fold compared to control
tissues (<5% of CD45+ cells) (Figure 4F). The percentage of
immature myeloid cells was higher also in esophageal and for-
estomach tumors (Figure 4F). Other types of immune cells
(macrophages, T cells, B cells, dendritic cells, NK cells) did not
increase with dysplasia and cancer (Figures 4E; Figure S3).
The fact that only one subpopulation of immune cells (imma-
ture myeloid cells) is specifically increased suggests that
p120ctn loss may lead to a highly selective process of immune
cell recruitment. We next purified splenic Gr-1+ CD11b+ cells
and prepared cytospins for cytology (Figure S3). Staining and
quantification revealed that the Gr-1+ CD11b+ cells represent
a range of cells, including myelocytes/metamyelocytes
(11.7%), segmented neutrophils (48.1%), band neutrophils
(12.5%), and monocytoid cells (7.7%). These cells have acti-
vated nuclear NFkB (Figure S3), consistent with what was found
in the mouse tumors (Figure 4A).
In order to evaluate the functional properties of the immature
myeloid cells, we again purified Gr-1+ CD11b+ cells from
tumor-bearing L2-Cre;p120loxP/loxP mice and found that
these cells inhibited peptide-specific T cell responses in vitro
(using OVA-specific TCR-transgenic T cells) (Figure 4G).Cancer Cell 19, 470–483, April 12, 2011 ª2011 Elsevier Inc. 473
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and have been suggested to suppress T cells (Figure 4H) (Bronte
et al., 2003; Bronte and Zanovello, 2005). We next treated
L2-Cre;p120loxP/loxP mice with dexamethasone and found
a dramatic attenuation of esophageal tumor invasion to that of
hyperplasia (Figures 5A; Figure S4). CD45+ cells and Gr-
1+CD11b+ cells were quantified by flow cytometry and were
reduced (Figure 5B; data not shown). We analyzed further these
Gr-1+CD11b+ cells and found decreased IL-4Ra expression in
the dexamethasone-treated mice (Figure 5C). Notably, IL-4Ra
expression onGr-1+CD11b+ cells has been reported to correlate
with suppression of CD8+ T cells (Gallina et al., 2006; Mandruz-
zato et al., 2009). These data suggest that inflammatory cells,
including the Gr-1+CD11b+ cells, are fostering tumorigenicity.
Desmoplasia Is Present in the Tumor Microenvironment
To evaluate the specific features of the microenvironment in the
invasive cancers that develop in L2-Cre;p120loxP/loxP mice,
a pronounced increase in fibrillar collagen was present in the
tumor stroma consistent with the desmoplasia in human ESCC
and OSCC (Figure 5D). By contrast, fibrillar collagen is localized
to a narrow region below the epithelium (Figure 5D). Additionally,
there was increased fibroblast specific protein-1 (Fsp1) expres-
sion in mouse OSCC and ESCC (Figure 5E). Similarly, a-smooth
muscle actin (aSMA) was increased in the mouse tumors (data
not shown). Interestingly, dexamethasone-treated mice had
resolution of the desmoplasia with little residual Fsp1+ fibro-
blasts (Figures 5E and 5F; Figure S4), suggesting a possible
role for the immune system in regulating desmoplasia in our
model system.
To evaluate a potential link between immature myeloid
cell inflammation and desmoplasia, we next conducted
coculture of purified Gr-1+CD11+ cells from tumor-bearing
L2-Cre;p120loxP/loxP mice with normal fibroblasts (from C57BL/
6 mice) and cancer (OSCC, ESCC) associated fibroblasts
(CAFs) (from L2-Cre;p120loxP/loxP mice) that revealed activation
of the normal fibroblasts and further augmentation of CAFs
based upon aSMA and Fsp1 expression (Figures 6A–6C). In
fact, some of the activated CAFs have an interesting ‘‘dendritic’’
appearance in coculture and display a similar morphology in
mouse tumors (Figure 6C). Furthermore, the Gr-1+CD11+ cells
survived better and expressed higher IL-4Ra levels in coculture
with CAFs (Figure 6D).
Given the different lines of evidence for the tumor-promoting
role of Gr-1+CD11+ cells in L2-Cre;p120loxP/loxP mice, we next
sought to determine a relationship between myeloid cells and
p120ctn loss in human ESCC. Increased myeloperoxidase
(MPO) staining in the tumor stroma for myeloid lineage cellsFigure 3. Histologic Analysis of Tumors from L2Cre;p120ctnloxP/loxP Mi
(A) H&E analyses of the esophagi, forestomachs, and oral cavities of 12-month-old
All control mice (five p120ctnloxP/loxP, ten L2Cre;p120ctn+/+, and eight L2Cre;p12
cation views of L2Cre;p120ctnloxP/loxP mice containing regions of invasive cance
tumor. Scale bars, 50 mM.
(B) IHC staining of 12-month-old mice for E-cadherin expression (four for each ge
of E-cadherin expression, and arrowhead indicates cytoplasmic localization of re
(C) IF of the esophagi and oral cavities of L2Cre;p120ctn+/+ and L2Cre;p120ctnlo
staining, and b-catenin staining. Arrows denote occasional regions of p120ctn an
both cancer types. b-Catenin was retained but mislocalized to the cytoplasm in
tumors. Asterisks denote regions of invasive cancers. Scale bars, 50 mM. See alcorrelates with p120ctn loss (Figure 7A; p = 0.05). This raises
the possibility that p120ctn loss might induce the recruitment
of MPO+ cells in the pathogenesis of human ESCC.
Secondary Alterations in Invasive Squamous
Cell Cancers
Apart from enhanced activation of NF-kB, Akt, and Stat-3 in the
tumor cells, and the probability that GM-CSF, MCP-1, and TNFa
are induced by NFkB in the tumor cells (Schreck and Baeuerle,
1990), we have begun to identify potential secondary alterations
in p120ctn-deficient squamous epithelia that may contribute to
cancer development. RNA microarray analysis was performed
using isolated epithelia from the esophagi and forestomachs
from 12-month-old L2-Cre;p120loxP/loxP mice and L2-Cre/
p120+/+ control mice. Unsupervised hierarchical clustering was
performed and identified significantly altered genes (Figure S5).
Several genes involved in cytokine signaling, IL-13Ra1, IL-1R2,
and Pias1, are altered in p120-deficient squamous epithelia
based upon microarray analysis and were confirmed by qPCR
(Figure S5).
DISCUSSION
p120-ctn Loss Results in Invasive Squamous
Cell Cancer
The complex between E-cadherin and p120-ctn is critical for
the formation and maintenance of the adherens junctions.
Disruption of this complex is a hallmark feature of epithelially
derived cancers. p120ctn loss or mislocalization can destabilize
E-cadherin. Definitive proof for p120ctn’s functional role as
a tumor suppressor gene in vivo has been elusive to date. Tar-
geted disruption of murine p120ctn in the salivary gland
(MMTV-cre;p120ctnflox/flox), skin (K14-cre;p120ctnflox/flox), and
intestine (Villin-Cre; p120ctnflox/flox) does not result in cancer
(Davis and Reynolds, 2006; Perez-Moreno et al., 2006;
Smalley-Freed et al., 2010). p120ctn may not be critical for
tumor suppression in these specific tissues. Alternatively,
a lack of tumor formation in these mice may be due to early
death. Generation and characterization of L2-Cre;p120loxP/loxP
mice result in a dramatic phenotype of invasive cancer in the
oral cavity, esophagus, and forestomach. These cancers may
be either unifocal or multifocal, and there is preceding severe
dysplasia, underscoring a temporal progression from preneo-
plasia to neoplasia, mirroring human OSCC and ESCC
progression.
How does p120ctn loss mechanistically cause invasive squa-
mous cell cancers? Concordant p120ctn and E-cadherin loss is
likely favoring cancer cell migration and invasion. Becausece
L2Cre;p120ctnloxP/loxPmice (n = 17) revealed invasive squamous cell cancers.
0ctn+/loxP) had no lesions. The bottom row of images denotes higher magnifi-
r (denoted by arrows). WD, well-differentiated tumor; PD, poorly differentiated
notype). Arrow indicates normal membrane localization. Asterisks indicate loss
sidual E-cadherin expression. Scale bars, 50 mM.
xP/loxP mice (four for each) for p120ctn (red)-E-cadherin (green) costaining, K14
d E-cadherin colocalization. K14 expression was detected in invading cells of
esophageal tumors. By contrast, b-catenin expression was lost in oral cavity
so Figure S2.
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Figure 4. Immature Myeloid Cells Are Recruited to the Esophagi and Squamous Forestomachs of L2Cre;p120ctnloxP/loxP Mice
(A) NFkB upregulation in L2Cre;p120ctnloxP/loxP mice. IHC staining for the NFkB p65 subunit revealed significant upregulation in hyperplastic, dysplastic, and
invasive cancer lesions in the esophagi of L2Cre;p120ctnloxP/loxP mice (n = 6). Arrows denote NFkB nuclear staining in immune cells within the stroma in
L2Cre;p120ctnloxP/loxP mice. Interestingly, these cells were found in early hyperplastic lesions. Scale bars, 50 mM.
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p120ctn Loss Results in Inflammation and Cancerp120ctn loss precedes E-cadherin loss in our model system, it is
unclear to what extent there is a dependence upon E-cadherin
loss.
E-cadherin destabilization or loss contributes to tumorigen-
esis. These squamous cancers induce prosurvival signals with
NF-kB, Akt, and p-Stat3 activation. In contrast to p120ctn loss
in skin with activated MAPK (Perez-Moreno et al., 2006),
p120ctn loss in oral and esophageal keratinocytes does not
have enhanced MAPK signaling. These squamous cell cancers
have striking features of desmoplasia and immune cell infiltra-
tion, with significant increases in immature myeloid cells, but
not in T cells, B cells, NK cells, dendritic cells, andmacrophages.
The precise recapitulation of human ESCC (along with OSCC) by
the conditional deletion of p120ctn is remarkable, and a definitive
in vivo genetic demonstration of p120ctn deletion resulting in
cancer.
The Tumor Microenvironment Is Critical in Mediating
the Effects of p120-ctn Loss
The tumor microenvironment is an array of diverse cell types that
cooperate to foster tumor cell migration and invasion. The extra-
cellular matrix includes invading tumor cells, fibroblasts (CAFs),
endothelial cells, pericytes, and immune cells (Andreu et al.,
2010; DeNardo et al., 2010; Kalluri and Zeisberg, 2006; Lewis
and Pollard, 2006).
Immature myeloid cell recruitment has been noted by IL-1b
overexpression in the stomach with resulting inflammation and
cancer (Tu et al., 2008), disruption of TGFb signaling inmammary
carcinomas (Yang et al., 2008), knock in of mutant K-ras to the
pancreas (Clark et al., 2007), and preparing the local pulmonary
environment for metastasis (Yan et al., 2010). We observed
a significant increase in immature myeloid cells in the tumor
microenvironment and the spleen. It is conceivable that GM-
CSF secreted by tumors contributes to the recruitment of imma-
ture myeloid cells (Marigo et al., 2010). We do not find evidence
of increased IL-1b, IL-6, VEGF, and prostaglandins from the
tumor cells, which have been linked also to the recruitment of
immature myeloid cells (Ostrand-Rosenberg and Sinha, 2009).
Other cell types in the tumor microenvironment might serve as
the sources for these other cytokines.
How do immature myeloid cells contribute to tumorigenesis?
Immature myeloid cells have the ability to suppress antigen-
specific T cell responses in vitro (Gabrilovich et al., 2001; Gallina(B) Western blot analysis of mouse-derived cell lines (F2-Tomato, F2-Cre, 714ET;
Akt, NFkB, and Stat3 activation (performed in triplicate). b-Actin is used as a loa
(C) Densitometry of western blot data from (B). All data are normalized to b-actin
(D) Cytokine analysis of conditioned media from F2-Tomato, F2-Cre, and 714 ET
M-CSF (p = 0.035), MCP-1 (p = 0.026), and TNFa (p = 0.005) in 714ET cells and inc
were given a value of zero for graphical purposes.
(E) Flow cytometry for CD45+ (total leukocytes) cells, Gr-1+ CD11b+ (immature m
and forestomach (right) of control mice (L2Cre;p120ctn+/+, blue diamonds; n = 4
bearing (TB) L2Cre;p120ctnloxP/loxP mice (red triangles; n = 3). Black horizontal b
(F) Representative flow cytometric results from (E) are depicted. Cells from the s
expression and then analyzed for Gr-1 (x axis) versus CD11b (y axis) expression
among CD45+ cells.
(G) Proliferation assay for T cells cocultured with Gr-1+CD11b+ cells at the indica
ratio of Gr-1+CD11b+ cells relative to T cells decreased, T cell proliferation increas
are <0.05 except 1:8 ratio for mouse 1387 when compared to no Gr-1+CD11b
L2Cre;p120ctnloxP/loxP mice, 1350, 1387). NO levels were increased in a titratableet al., 2006; Sinha et al., 2005). In our model system, immature
myeloid cells isolated from tumor-bearing mice also have the
ability to inhibit T cell activation. Additionally, the immature
myeloid cells activate normal fibroblasts and augment activation
of CAFs based upon Fsp1 and aSMA expression, which are
novel findings. In turn, CAFs in our system contribute to pro-
longed survival of immature myeloid cells. We cannot exclude
other protumorigenic functions of immature myeloid cells in
our model system related to angiogenesis, secretion of chemo-
kines/cytokines, and production of ECM-degrading enzymes
(DeNardo et al., 2009, 2010; Ferrara, 2010; Gabrilovich and
Nagaraj, 2009; Ostrand-Rosenberg and Sinha, 2009; Yang
et al., 2004, 2008). Because dexamethasone has protean
effects, it will be important to ablate immature myeloid cells in
a specific fashion in our model system and in those models
where immature myeloid cells are thought to be critical.
In summary, conditional p120ctn loss in the esophagus, oral
cavity, and forestomach leads to invasive squamous cell
cancers, involving NFkB, Akt, Stat-3 activation, increased
proliferation, and production of GM-CSF, M-CSF, MCP-1, and
TNFa from tumor-derived cells. The accompanying tumor
microenvironment is replete with desmoplasia and immature
myeloid cells. These events likely contribute to cancer arising
from p120ctn-deficient cells (Figure 7), which provide compel-
ling evidence that p120ctn is indeed a bona fide tumor
suppressor gene. Because the L2-Cre;p120loxP/loxP mice phe-
nocopy human OSCC and ESCC, they serve as a model for
the translational development of diagnostic and therapeutic
agents, goals that have been hindered by the absence of
robust, genetically based models. Furthermore, our model
might be applicable to other squamous cancers given common
genomic alterations between ESCC and lung SCC where
SOX-2 is amplified (Bass et al., 2009). Several approaches
merit consideration in this context. First, strategies designed
to restore wild-type p120ctn may provide a venue to ameliorate
tumor progression. Given the complex nature of the tumor
microenvironment, targeting of components, either individually
or in combination, might advance the field. For example, pro-
drugs have been demonstrated to be efficacious against
fibroblast activation protein (FAP) in prostate cancer (Lebeau
et al., 2009). Strategies to target immature myeloid cells might
be attractive based upon our studies as well in pancreatic
cancer (Clark et al., 2007).see Experimental Procedures) were used to investigate p120ctn loss as well as
ding control.
.
cells (three for each cell line). ELISAs revealed increased GM-CSF (p = 0.040),
reasedMCP-1 in F2-Cre cells (p = 1.63 105). Nondetectable ELISA readings
yeloid) cells, and F4/80+ macrophages in the spleen (left), esophagus (middle),
), L2Cre;p120ctnloxP/loxP mice with dysplasia (yellow circles; n = 4), and tumor-
ars are mean percentages for each group. See p values in Figure S3.
pleen (left), esophagus (middle), and forestomach (right) were gated for CD45
. Numbers represent percentages of Gr-1+ CD11b+ (immature myeloid cells)
ted cell ratios. Gr-1+CD11b+ cells suppressed T cell proliferation (n = 6). As the
ed (two with 1350, 1387 representing L2Cre;p120ctnloxP/loxPmice). All p values
+ cells. (H) Nitric oxide (NO) in the conditioned media was determined (two
manner. Error bars indicate SEM. See also Table S2 and Figure S3.
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Figure 5. The Immune Response Is Involved in the Tumor Microenvironment in L2Cre;p120ctnloxP/loxP Mice
(A) Dexamethasone (Dex) or PBS (control) was administered to 8-month-old L2Cre;p120ctnloxP/loxPmice (five in each group) for 7 days. Histologic examination of
the esophagi revealed hyperplasia without desmoplasia or inflammation in the Dex-treated mice, whereas invasive esophageal squamous cancer with des-
moplasia and inflammation was present in PBS-treated mice. Arrows point to regions of invasion. Scale bars, 100 mM.
(B) FACS analysis for CD45+ cells containedwithin the esophagi fromDex-treatedmice (red bars) and PBS control mice (green bars) (five in each group; p = 0.01).
Dex treatment reduced CD45+ and Gr-1+CD11b+ cells by 6-fold.
(C) FACS analysis for IL-4Ra+ cells contained within the Gr-1+CD11b+ population of cells from Dex-treated mice (red bars) and PBS control mice (green bars)
(five in each group; p = 0.0016). Dex reduced the percentage of Gr-1+ CD11b+ cells that express IL-4Ra by about 50%.
(D) Masson’s trichrome staining on esophagi of L2Cre;p120ctnloxP/loxP mice (n = 4) and control (L2Cre;p120ctn+/+) mice. Asterisks indicate the fibrillar
collagen layer in the control L2Cre;p120ctn+/+ esophagi. Arrows indicate the abundant fibrillar collagen surrounding invasive esophageal tumors (upper right
and lower right panels). Invasive oral and forestomach tumors in L2Cre;p120ctnloxP/loxP mice are depicted in the bottom row. Arrows indicate the staining
surrounding invasive cancers. Scale bars, 50 mM.
Cancer Cell
p120ctn Loss Results in Inflammation and Cancer
478 Cancer Cell 19, 470–483, April 12, 2011 ª2011 Elsevier Inc.
Figure 6. Crosstalk between Immature Myeloid Cells and Fibroblasts in the Tumor Microenvironment of L2Cre;p120ctnloxP/loxP Mice
(A) Fibroblasts from the oral cavity of wild-type mice (designated as OF3) or oral CAFs [designated as 1136CF]) from L2Cre;p120ctnloxP/loxP mice were analyzed
in coculture with Gr-1+CD11b+ cells for Fsp1 expression by IF. Cocultured fibroblasts had increased Fsp1 expression (n = 6). Scale bars, 50 mM.
(B) Cocultured fibroblasts had increased aSMA expression (n = 6). Scale bars, 50 mM.
(C) An esophageal CAF cell line (955EF) had high basal Fsp1 expression when cultured alone. Coculturing of 955EF cells (n = 6) resulted in even higher Fsp1
expression. Note that the highest Fsp1+ 955EF cells have ‘‘dendrite-like’’ projections, which is evident also in esophageal tumors from L2Cre;p120ctnloxP/loxP
mice (n = 4). Scale bars, 50 mM.
(D) FACS revealed increased survival of Gr-1+CD11b+ cells in coculture with CAFs (n = 4; p = 0.021). (E) FACS demonstrated increased IL-4Ra expression in
Gr-1+CD11b+ cells in coculture with CAFs (n = 4; p = 0.016). Error bars indicate SEM.
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Cell Lines
TE and HCE cells, all established human esophageal squamous cancer cell
lines, were cultivated in DMEM media supplemented by 10% fetal calf serum
(Sigma-Aldrich) and 1% penicillin/streptomycin (Invitrogen) and grown in 5%
CO2 conditions as described previously (Okano et al., 2000). Cell lines were
established from mouse esophageal tumors (designated as 714ET), mouse
fibroblasts (designated as OF3 from normal oral cavity), and mouse CAFs
(designated as 1136CF from OSCC and designated as 955EF from ESCC)(E) Fsp1 IF with increased expression in esophageal and oral cavity tumors from L
(n = 4) tissues. Scale bar, 50 mM.
(F) Fsp1 IF of esophagi from L2Cre;p120ctnloxP/loxPmice treated with either PBS o
when compared to PBS treated mice (n = 5). Scale bars, 50 mM. See also Figureand verified to be of epithelial or fibroblast origin. The mouse cell lines were
cultivated in DMEM as above.
To generate pBABE-tdTomato-SV40-nlsCre (6982 bp), puromycin acetyl-
transferase of pBABE-puro was replaced with nlsCre cDNA derived from
pHRnlsCre (Addgene), and then tdTomato cDNA (gift of Roger Y. Tisen,
University of California, San Diego, San Diego, CA, USA) was subcloned.
The parental F2 cells were established through the isolation of esophageal
epithelia (Opitz et al., 2002) from p120loxP/loxPmice, infected with pBABE-tdTo-
mato-SV40-nlsCre (designated as F2-Cre) or pBABE-tdTomato (designated
as F2-Tomato), and stable clones were FACS selected for tdTomato. The2Cre;p120ctnloxP/loxP mice (n = 4) compared to control L2Cre;p120ctn+/+ mice
r Dex from Figure 5A. Fsp1 expression is decreased in Dex-treated mice (n = 5)
S4. Error bars indicate SEM.
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Figure 7. MPO Expression in Human ESCC
(A) MPO expression was analyzed by IF in 14 ESCC samples with matched adjacent normal esophageal mucosa. Representative image is depicted with
MPO-positive cells present in the tumor stroma (right panel). MPO staining was increased in the tumor stroma and correlates with p120ctn loss (p = 0.05, Fisher’s
exact analysis). Scale bars, 50 mM.
(B) Model of OSCC and ESCC in conditional p120ctn-deleted mice. Solid lines represent cell-cell interactions emerging from experiments in this study. Dashed
lines are potential areas of interactions. See also Figure S5.
Cancer Cell
p120ctn Loss Results in Inflammation and CancerF2-Cre and F2-Tomato cell lines were cultivated in KSFM as described previ-
ously (Andl et al., 2003; Harada et al., 2003).
Histology and IHC/IF
Paraffin tissue sectioning and staining for hematoxylin and eosin (H&E) and IHC
were performed as described previously (Stairs et al., 2008). Antibodies used
for IHC were the following: p120ctn (610134; BD Transduction); E-cadherin
(610182; BD Transduction); K14 (PRB-155P; Covance); pAKT (9271; Cell480 Cancer Cell 19, 470–483, April 12, 2011 ª2011 Elsevier Inc.Signaling);pMAPK(9101;CellSignaling);NFkB-p65subunit (4764;CellSignaling);
andKi67 (NCL-KI67p;Novacastra). For IF the followingantibodieswereused:K14
(PRB-155P; Covance); Fsp1 (DakoCytomation); b-catenin (9562; Cell Signaling);
p120ctn (61634; BD Transduction); E-cadherin (3195; Cell Signaling); c-myc
(1472-1; Epitomics); MPO (45977; Abcam); p-Stat3 (9145; Cell Signaling); and
aSMA (A2547; Sigma). Secondary antibodies used were: Alexa Fluor 488-anti-
rabbit, Alexa Fluor 568 anti-rat, or Alexa Fluor 568 anti-mouse. Slideswere cover-
slipped using VectaShield mounting medium with DAPI.
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TMAs were created using 69 matched paraffin blocks from de-identified
patients with primary ESCC and adjacent normal esophageal tissues (with
Institutional Review Board exempt status for the TMA due to the de-identifica-
tion). Scoring of p120ctn, E-cadherin, and MPO IHC was based upon a quan-
titative evaluation of expression using a scale from 0 to 2 (0, absent; 1, mild-
moderate; 2, high) and performed by A.K.-S., pathologist, in a blinded fashion.
Fisher’s exact test was used.
Generation of Mouse Models
The Institutional Animal Care and Use Committee (IACUC) at the University
of Pennsylvania approved all animal studies. Mice were housed under
a 12-hr light/dark cycle and fed ad libitum. LoxP-flanked p120ctn mice were
generated previously (Davis and Reynolds, 2006). L2Cre transgenic mice
were generated by cloning Cre recombinase under the control of the EBV
ED-L2 promoter (Nakagawa et al., 1997; Opitz et al., 2002). Mice were geno-
typed for the LoxP allele as described previously (Davis and Reynolds,
2006). Mice were genotyped for L2Cre by PCR analysis using primers con-
tained within the Cre (forward: GGCCAGCTAAACATGCTTCATCGT; reverse:
ACGTAACAGGGTGTTATAAGCAAT). PCR conditions were 35 cycles at
94C for 45 s, 61C for 45 s, and 72C for 1 min, 30 s. Additionally, L2Cre
mice were bred with Gt(Rosa)26Tm1Sor reporter mice, and tissues were sub-
jected to LacZ staining as described previously (Brembeck et al., 2001).
Dexamethasone Treatment
L2-Cre;p120loxP/loxPmice were injected intraperitoneally with either dexameth-
asone 10 mg/kg/day or PBS (control) for 7 days. After 7 days, mice were sacri-
ficed, and the esophagi and spleens were excised for histology and FACS
analysis.
Flow Cytometry
Single-cell suspensions of fresh spleens, esophagi, and squamous forestom-
achs were prepared from genetically engineered mice and littermate controls.
Spleens were crushed and passed through a 70 mm cell strainer, treated with
ACK Lysis Buffer (Invitrogen) and washed twice with RPMI/10% FCS.
Esophagi and forestomachs were minced into 1–2 mm pieces, incubated in
1 mg/ml collagenase (Sigma-Aldrich) in RPMI for 45 min at 37C, and then
were passed through a 70 mm cell strainer and washed once with RPMI/
10% FCS. Cells were stained in PBS/0.5% FCS with the following antibodies:
CD45 (clone 30-F11), CD11c (clone HL3), Gr-1 (clone RBG-8C5), CD11b
(clone M1/70), CD33 (clone 145-2C11), CD49b (clone DX5), CD19 (clone
1D3), CD124 (clone mIL-4R-M1), and rat IgG2a, k (clone R35-95) from BD
Biosciences PharMingen and F4/80 (clone C1:A3-1) from AbD Serotec. Flow
cytometry was done using a BD FACSCanto (BD Biosciences Immunocytom-
etry Systems), and data were analyzed with BD FACSDiva software.
Gr-1+ CD11b+ Cell Isolation and Functional T Cell
Suppression Assay
Gr-1+ CD11b+ cells were isolated from spleens using biotinylated anti-Gr-1
mAb, magnetic beads, and MiniMACS columns (Miltenyi Biotec). The purity
was >90% Gr-1+ CD11b+ cells by flow cytometry. Antigen-specific suppres-
sion of CD8+ T cells was evaluated using splenocytes from OT-1 transgenic
mice as responder cells. OT-1 splenocytes were seeded in triplicates in 96-
well round-bottom plates (7 3 105/well) and stimulated with cognate antigen,
OVA-derived peptide SIINFEKL (1 mg/ml; New England Peptide), and cultured
for 4 days in the presence of increasing ratios of Gr-1+ CD11b+ cells. Eighteen
hours before harvesting, cells were pulsed with [3H]thymidine (1 mCi per well;
Amersham Biosciences). [3H]Thymidine incorporation was assessed using
a liquid scintillation counter and expressed as cpm. Student’s t test was used.
NO Production
NO production by Gr-1+ CD11b+ cells was evaluated in culture supernatant
from T cell suppression assays using the Griess Reagent System (Promega).
Equal volumes of culture supernatant (40 ml) were mixed with 1% sulfanilamide
in 5% phosphoric acid and incubated at RT for 10 min, followed by addition of
0.1% N-1-naphthylethylenediamine dihydrochloride in water. After a 10-min
incubation at RT, absorbance (550 nm) was measured using a microplate
reader. Nitrite concentrations were determined by comparing the absorbancefor the test samples to a standard curve generated by serial dilution of 0.1 mM
sodium nitrite. Student’s t test was used.
Coculture of Immature Myeloid Cells and Fibroblasts
Immature myeloid cells were cocultured with fibroblasts for 96 hr, and fibro-
blasts were evaluated for aSMA and Fsp1. Immature myeloid cells were eval-
uated for survival and IL-Ra expression. Student’s t test was used.
Cytology of Gr-1+ CD11b+ Cells
Gr-1+ CD11b+ cells were purified (>98%) from spleens of tumor-bearing mice
using a MoFlo fluorescence activated cell sorter (DakoCytomation). Cytospin
preparations were stained with Diff-Quick reagent and by IF for NFkB.
Cytokine Analysis
The following cytokines were measured either by BD Cytokine Bead Array (BD
Biosciences) or by ELISA (R&D Systems): IL-1b, IL-2, IL-4, IL-5, IL-6, IFNg,
TNFa, GM-CSF, G-CSF, MCP-1, KC, M-CSF, SCF, and VEGF.
RNA Microarrays
The epithelia from mouse esophagi and squamous forestomachs were iso-
lated by digesting the tissues with a 1:2 dilution dispase (BD) in deionized
water at 37C for 5–10 min. The epithelia were peeled and snap-frozen and
stored at 80C for RNA isolation. RNA was purified, and cRNA was prepped
(Affymetrix) and run on Affymetrix Mouse 1.0ST Affymetrix Arrays.
Statistical Analysis of RNA Microarray Data
Gene expression differences were considered statistically significant if the
p value was less than 0.01. A global test was done as to whether the expres-
sion profiles differed between the classes by permuting the labels of which
arrays corresponded to which classes. For each permutation the p values
were recomputed, and the number of genes significant at the 0.01 level was
noted. The false discovery rate was estimated to be less than 10%. Cluster
analysis was performed with Cluster and TreeView software (Eisen et al.,
1998).
ACCESSION NUMBERS
Coordinates have been deposited in the GEO database with accession code
GSE20240.
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